Stay updated with breaking news from Patrickj Haley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exelixis (NASDAQ:EXEL – Get Free Report) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Thursday. A number of other research analysts also recently weighed in on EXEL. SVB Securities began coverage on shares of Exelixis in a research report on Tuesday, August […]
Exelixis (NASDAQ:EXEL – Free Report) had its price target raised by JMP Securities from $24.00 to $27.00 in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The brokerage currently has an outperform rating on the biotechnology company’s stock. EXEL has been the subject of a number of other research reports. StockNews.com initiated […]
Tekla Capital Management LLC purchased a new position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 726,639 shares of the biotechnology company’s stock, valued at approximately $14,104,000. Tekla Capital Management LLC owned 0.22% of Exelixis […]
SVB Leerink assumed coverage on shares of Exelixis (NASDAQ:EXEL – Free Report) in a report published on Tuesday, Benzinga reports. The brokerage issued a market perform rating and a $18.00 target price on the biotechnology company’s stock. Several other equities research analysts also recently weighed in on the company. Oppenheimer reaffirmed an outperform rating and […]
Meritage Portfolio Management lifted its stake in Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 164.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 424,235 shares of the biotechnology company’s stock after purchasing an additional 264,052 shares during the quarter. Meritage Portfolio Management’s […]